Ophthalmology, Retina Specialist · Stuart, FL
NPI
1659529055
Since 2008
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1050 SE Monterey Road, Suite #104, Florida Vision Institute Inc.
Stuart, FL, 34994
Phone (772) 283-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
45,613 services
Medicare patients, 2024
1,632
Average age 77
Drug cost, 2024
$2.9M
1,570 prescriptions
Company payments, 2025
$462
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Walid Mangal was code J2777 (injection, faricimab-svoa, 0.1 mg), 32,820 times for 108 patients. In total Walid Mangal billed 45,613 services in 32 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 32,820 | 108 | $27.55 | $904K |
| 99213 Office E&M - Established | Office | 2,448 | 1,359 | $63.98 | $157K |
| 92134 Computerized Ophthalmic Imaging | Office | 2,184 | 959 | $29.09 | $64K |
| 67028 Intravitreal Injection | Office | 1,201 | 278 | $91.15 | $109K |
| 92250 Angiography | Office | 1,013 | 793 | $26.32 | $27K |
| 92242 Angiography | Office | 900 | 305 | $214.49 | $193K |
| 92273 Test - Miscellaneous | Office | 851 | 591 | $88.81 | $76K |
| J0178 Injection, aflibercept, 1 mg | Office | 736 | 103 | $659.00 | $485K |
| 99214 Office E&M - Established | Office | 611 | 434 | $91.79 | $56K |
| 92235 Angiography | Office | 561 | 380 | $120.99 | $68K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 368 | 14 | $264.53 | $97K |
| 76512 Ultrasound - Nonspecific | Office | 364 | 317 | $54.40 | $20K |
| J7999 Compounded drug, not otherwise classified | Office | 346 | 107 | $63.37 | $22K |
| 92287 Angiography | Office | 216 | 141 | $111.47 | $24K |
| 67210 Eye | Office | 111 | 74 | $403.61 | $45K |
By year: 2022 $2.4M for 20,406 services; 2023 $2.6M for 45,477 services; 2024 $2.5M for 45,613 services.
Medicare prescription drug claims, 2024
In 2024, the drug Walid Mangal prescribed most often to Medicare patients was Vabysmo (Faricimab-Svoa), with 534 prescriptions and refills. In total Walid Mangal wrote 1,570 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vabysmo Faricimab-Svoa | 534 | 563 | 125 | $1.4M |
| Eylea Aflibercept | 493 | 508 | 151 | $1.1M |
| Prednisolone Acetate Generic | 135 | 182 | 84 | $5,272 |
| Eylea Hd Aflibercept | 74 | 81 | 16 | $250K |
| Latanoprost Generic | 57 | 91 | 21 | $422 |
| Brimonidine Tartrate Generic | 50 | 100 | 22 | $302 |
| Ozurdex Dexamethasone | 36 | 69 | 14 | $56K |
| Ofloxacin Generic | 35 | 41 | 34 | $508 |
| Timolol Maleate Generic | 34 | 76 | 14 | $336 |
| Difluprednate Generic | 19 | 22 | 14 | $2,363 |
| Beovu Brolucizumab-Dbll | 17 | 18 | Under 11 | $39K |
| Ketorolac Tromethamine Generic | 16 | 25 | Under 11 | $442 |
| Combigan Brimonidine Tartrate/Timolol | 12 | 15 | Under 11 | $2,706 |
| Atropine Sulfate Generic | 11 | 11 | Under 11 | $160 |
Brand drugs: 1,349 claims; generic drugs: 221 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walid Mangal $462 ($462 in general payments such as food, travel and fees) from 7 companies. The largest payer was Astellas Pharma US Inc with $127.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.